Gum-Disease
发表于 2025-3-26 21:27:10
http://reply.papertrans.cn/83/8258/825727/825727_31.png
Receive
发表于 2025-3-27 03:59:29
http://reply.papertrans.cn/83/8258/825727/825727_32.png
纹章
发表于 2025-3-27 07:11:02
Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland,efly described, as are Swiss-specific terminologies such as the term “transplant product,” which means products manufactured from cells, tissues, or even whole organs. Although some parts of this chapter may show a guideline character, they are not legally binding, but represent the current thinking
教义
发表于 2025-3-27 10:12:42
http://reply.papertrans.cn/83/8258/825727/825727_34.png
countenance
发表于 2025-3-27 15:02:11
http://reply.papertrans.cn/83/8258/825727/825727_35.png
吹气
发表于 2025-3-27 20:23:49
Regulation of Cell and Gene Therapy Medicinal Products in Taiwan,more and more cell or gene medicinal therapy products have been approved for marketing, to treat serious diseases which have been challenging to treat with current medical practice or medicine. This chapter will briefly introduce the Taiwan Food and Drug Administration (TFDA) and elaborate regulatio
下边深陷
发表于 2025-3-27 22:44:11
Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Siare working towards establishing a risk-based system in the regulatory framework. Similarly in Singapore, a risk-based tiered approach has been applied whereby clinical trials and product licence of high-risk cell- and tissue-based therapeutic products (substantially manipulated products, products i
obviate
发表于 2025-3-28 03:20:15
http://reply.papertrans.cn/83/8258/825727/825727_38.png
俗艳
发表于 2025-3-28 09:30:18
Regulatory Frameworks for Gene and Cell Therapies in Japan,accompanying guidelines for these two Acts are currently in preparation. It is expected that the new legislative frameworks will promote the timely development of new products and technologies, to bring safe and effective regenerative medicines to Japanese patients.
SPURN
发表于 2025-3-28 13:50:20
http://reply.papertrans.cn/83/8258/825727/825727_40.png